Status:
COMPLETED
Testing the Helpfulness of 2 Decision Aids for Prostate Cancer
Lead Sponsor:
VA Office of Research and Development
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
The purpose of this study is to test different methods for communicating information about prostate cancer treatment to men. The investigators are studying how best to present information so men can m...
Detailed Description
Background/Rationale: Prostate cancer is the second leading cause of cancer related death among men in the United States, and accounts for 29% of all cancers diagnosed in men. Furthermore, approximate...
Eligibility Criteria
Inclusion
- Men undergoing a prostate cancer biopsy at Ann Arbor, Durham, San Francisco, or Pittsburgh VAs. Additional inclusion criteria includes ability to speak English, provide informed consent, and have a PSA \< 20.
Exclusion
- Prior history of prostate cancer
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
1028 Patients enrolled
Trial Details
Trial ID
NCT00432601
Start Date
August 1 2008
End Date
September 1 2012
Last Update
March 22 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Medical Center, San Francisco
San Francisco, California, United States, 94121
2
VA Ann Arbor Healthcare System
Ann Arbor, Michigan, United States, 48113-0170
3
VA Medical Center
Durham, North Carolina, United States, 27705
4
Center for Health Equity Research and Promotion
Pittsburgh, Pennsylvania, United States, 15240